0 results available. Select is focused ,type to refine list, press Down to open the menu,
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, In...
The following section summarizes insights on Johnson & Johnson's Total Debt / EBITDA:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Total Debt / EBITDA in the risk category include:
A ratio that is calculated as Total Debt (including Capital Leases) divided by EBITDA.
Total Debt / EBITDA ratio measures leverage in terms of total debt while using EBITDA as a proxy for cash flow.
Short Term Borrowings
(+) Current Portion of Long Term Debt
(+) Current Portion of Lease Liabilities
(+) Long Term Debt
(+) Long Term Lease Liabilities
(=) Total Debt
EBITDA is Earnings before Interest, Taxes, Depreciation & Amortization
The chart above depicts the distribution of total debt / ebitda for companies operating in the Healthcare sector in the Developed economic region. Over 2,140 companies were considered in this analysis, and 2,059 had meaningful values. The average total debt / ebitda of companies in the sector is 0.5x with a standard deviation of 3.3x.
Johnson & Johnson's Total Debt / EBITDA of 1.3x ranks in the 75.0% percentile for the sector. The following table provides additional summary stats:
Economic Risk Region | Developed |
Total Constituents | 2,145 |
Included Constituents | 2,059 |
Min | -14.7x |
Max | 16.6x |
Median | 0.0x |
Mean | 0.5x |
Standard Deviation | 3.3x |
You can find companies with similar total debt / ebitda using this stock screener.